Major trial aims to keep people on HIV prevention drugs
NCT ID NCT07221747
Summary
This study aims to find the best ways to help people in Malawi continue taking HIV prevention medication. It will test a package of support strategies at clinics and community centers, focusing on helping people stay on either daily pills or a newer long-acting injection. The goal is to see which approach helps people continue their prevention regimen for at least five months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL PRE-EXPOSURE PROPHYLAXIS (PREP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Community Health Science Unit
RECRUITINGLilongwe, Malawi
Contact
Conditions
Explore the condition pages connected to this study.